Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Also employed in research for novel antiviral compounds due to its heterocyclic framework, which mimics purine bases. Shows potential in medicinal chemistry for optimizing drug candidates with improved metabolic stability and bioavailability.